Elissa Vaughn
Psychiatric/Mental Health · Jeffersonville, INNPI 1033539481
Payments from drug & device makers
Across 183 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$700
- AbbVie$494
- Teva Pharmaceuticals USA, Inc.$420
- Otsuka America Pharmaceutical, Inc.$340
- Neurocrine Biosciences, Inc.$314
- Alkermes, Inc.$303
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,47796%
- Education$1524%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $700 |
| AbbVie | 36 | $494 |
| Teva Pharmaceuticals USA, Inc. | 16 | $420 |
| Otsuka America Pharmaceutical, Inc. | 23 | $340 |
| Neurocrine Biosciences, Inc. | 14 | $314 |
| Alkermes, Inc. | 14 | $303 |
| E.r. Squibb & Sons, L.L.C. | 8 | $253 |
| Johnson & Johnson | 7 | $226 |
| Lundbeck LLC | 15 | $222 |
| Indivior Inc. | 3 | $135 |
| Vanda Pharmaceuticals Inc. | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Tris Pharma Inc | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$477
- VRAYLAR$245
- CAPLYTA$239
- COBENFY$121
- UZEDY$120
- ARISTADA INITIO$119
- INGREZZA$118
- INVEGA SUSTENNA$110
- INVEGA TRINZA$110
- SUBLOCADE$103
How this compares
$3,630 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 11 | $166 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Jeffersonville
- Paul DuncanJeffersonville$46K
- Anthony AemmerJeffersonville$9K
- Matthew CulbrethJeffersonville$7K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.